Albireo Moves Closer to Having First Approved Drug for Pediatric PFIC

Albireo Moves Closer to Having First Approved Drug for Pediatric PFIC

Source: 
BioSpace
snippet: 

AstraZeneca spinout Albireo Pharma is moving closer to securing regulatory approval for its treatment of pruritus in patients with progressive familial intrahepatic cholestasis (PFIC).